Fourpath Capital Management’s Sanofi SNY Stock Holding History

Fourpath Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34M	Buy	31,493 +5,531	+21%	+$247K	0.18%	98
2026 Q1	$1.25M	Buy	25,962 +6,149	+31%	+$287K	0.18%	89
2025 Q4	$960K	Sell	19,813 -227	-1%	-$11.3K	0.13%	105
2025 Q3	$946K	Buy	20,040 +44	+0.2%	+$2.12K	0.13%	104
2025 Q2	$966K	Sell	19,996 -659	-3%	-$33.7K	0.15%	97
2025 Q1	$1.15M	Buy	20,655 +2,808	+16%	+$152K	0.2%	86
2024 Q4	$861K	Sell	17,847 -620	-3%	-$31.5K	0.16%	97
2024 Q3	$1.06M	Buy	18,467 +602	+3%	+$32.5K	0.2%	90
2024 Q2	$867K	Buy	17,865 +4,366	+32%	+$211K	0.64%	31
2024 Q1	$656K	Buy	13,499 +4,562	+51%	+$223K	0.46%	51
2023 Q4	$444K	Sell	8,937 -3,358	-27%	-$164K	0.3%	74
2023 Q3	$660K	Sell	12,295 -18	-0.1%	-$960	0.49%	47
2023 Q2	$664K	Buy	12,313 +2,524	+26%	+$136K	0.8%	40
2023 Q1	$533K	Buy	+9,789	New	+$476K	0.37%	68

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fourpath Capital Management's SNY Position: Q2 2026 in Review

Fourpath Capital Management increased its Sanofi (SNY) stake by 21% in Q2 2026, buying an estimated $247K and bringing the position to 31,493 shares worth $1.34M. The position accounts for 0.18% of the portfolio, ranked #98.

Fourpath Capital Management first reported a position in SNY in Q1 2023 and has held it in 14 quarters since. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Fourpath Capital Management held 31,493 shares of Sanofi worth $1.34M as of Q2 2026.
Fourpath Capital Management bought 5,531 Sanofi shares in Q2 2026, an estimated $247K.
Sanofi made up 0.18% of Fourpath Capital Management's portfolio in Q2 2026, its #98 holding.
Fourpath Capital Management first reported a position in Sanofi in Q1 2023 and has held it in 14 quarters since.
716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Fourpath Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.